173 related articles for article (PubMed ID: 17445843)
21. Behavioral evidence linking opioid-sensitive GABAergic neurons in the ventrolateral periaqueductal gray to morphine tolerance.
Morgan MM; Clayton CC; Lane DA
Neuroscience; 2003; 118(1):227-32. PubMed ID: 12676152
[TBL] [Abstract][Full Text] [Related]
22. Systemic morphine-induced release of serotonin in the rostroventral medulla is not mimicked by morphine microinjection into the periaqueductal gray.
Taylor BK; Basbaum AI
J Neurochem; 2003 Sep; 86(5):1129-41. PubMed ID: 12911621
[TBL] [Abstract][Full Text] [Related]
23. RGS14 prevents morphine from internalizing Mu-opioid receptors in periaqueductal gray neurons.
Rodríguez-Muñoz M; de la Torre-Madrid E; Gaitán G; Sánchez-Blázquez P; Garzón J
Cell Signal; 2007 Dec; 19(12):2558-71. PubMed ID: 17825524
[TBL] [Abstract][Full Text] [Related]
24. Nifedipine potentiates the antinociceptive effect of endomorphin-1 microinjected into the periaqueductal gray in rats.
Cousins MJ; Hao S; Mamiya K; Takahata O; Iwasaki H; Mata M; Fink DJ
Anesth Analg; 2003 Apr; 96(4):1065-1071. PubMed ID: 12651662
[TBL] [Abstract][Full Text] [Related]
25. Lack of Antinociceptive Cross-Tolerance With Co-Administration of Morphine and Fentanyl Into the Periaqueductal Gray of Male Sprague-Dawley Rats.
Bobeck EN; Schoo SM; Ingram SL; Morgan MM
J Pain; 2019 Sep; 20(9):1040-1047. PubMed ID: 30853505
[TBL] [Abstract][Full Text] [Related]
26. Behavioral consequences of delta-opioid receptor activation in the periaqueductal gray of morphine tolerant rats.
Morgan MM; Ashley MD; Ingram SL; Christie MJ
Neural Plast; 2009; 2009():516328. PubMed ID: 19266049
[TBL] [Abstract][Full Text] [Related]
27. Contribution of the periaqueductal gray to the suppression of pain affect produced by administration of morphine into the intralaminar thalamus of rat.
Munn EM; Harte SE; Lagman A; Borszcz GS
J Pain; 2009 Apr; 10(4):426-35. PubMed ID: 19231299
[TBL] [Abstract][Full Text] [Related]
28. Loss of TRPV1-expressing sensory neurons reduces spinal mu opioid receptors but paradoxically potentiates opioid analgesia.
Chen SR; Pan HL
J Neurophysiol; 2006 May; 95(5):3086-96. PubMed ID: 16467418
[TBL] [Abstract][Full Text] [Related]
29. The chemokine CX3CL1/fractalkine interferes with the antinociceptive effect induced by opioid agonists in the periaqueductal grey of rats.
Chen X; Geller EB; Rogers TJ; Adler MW
Brain Res; 2007 Jun; 1153():52-7. PubMed ID: 17459345
[TBL] [Abstract][Full Text] [Related]
30. PAG mu opioid receptor activation underlies sex differences in morphine antinociception.
Bernal SA; Morgan MM; Craft RM
Behav Brain Res; 2007 Feb; 177(1):126-33. PubMed ID: 17118467
[TBL] [Abstract][Full Text] [Related]
31. Role of kappa and delta opioid receptors in mediating morphine-induced antinociception in morphine-tolerant infant rats.
Stoller DC; Sim-Selley LJ; Smith FL
Brain Res; 2007 Apr; 1142():28-36. PubMed ID: 17300766
[TBL] [Abstract][Full Text] [Related]
32. Involvement of cholecystokinin in the opioid tolerance induced by dipyrone (metamizol) microinjections into the periaqueductal gray matter of rats.
Tortorici V; Nogueira L; Aponte Y; Vanegas H
Pain; 2004 Nov; 112(1-2):113-20. PubMed ID: 15494191
[TBL] [Abstract][Full Text] [Related]
33. Mu-opioid and CB1 cannabinoid receptors of the dorsal periaqueductal gray interplay in the regulation of fear response, but not antinociception.
Godoi MM; Junior HZ; da Cunha JM; Zanoveli JM
Pharmacol Biochem Behav; 2020 Jul; 194():172938. PubMed ID: 32376258
[TBL] [Abstract][Full Text] [Related]
34. Drug dependent sex-differences in periaqueducatal gray mediated antinociception in the rat.
Bobeck EN; McNeal AL; Morgan MM
Pain; 2009 Dec; 147(1-3):210-6. PubMed ID: 19796879
[TBL] [Abstract][Full Text] [Related]
35. Relative contribution of the dorsal raphe nucleus and ventrolateral periaqueductal gray to morphine antinociception and tolerance in the rat.
Campion KN; Saville KA; Morgan MM
Eur J Neurosci; 2016 Nov; 44(9):2667-2672. PubMed ID: 27564986
[TBL] [Abstract][Full Text] [Related]
36. Tolerance to repeated morphine administration is associated with increased potency of opioid agonists.
Ingram SL; Macey TA; Fossum EN; Morgan MM
Neuropsychopharmacology; 2008 Sep; 33(10):2494-504. PubMed ID: 18046309
[TBL] [Abstract][Full Text] [Related]
37. Analgesic tolerance to high-efficacy agonists but not to morphine is diminished in phosphorylation-deficient S375A μ-opioid receptor knock-in mice.
Grecksch G; Just S; Pierstorff C; Imhof AK; Glück L; Doll C; Lupp A; Becker A; Koch T; Stumm R; Höllt V; Schulz S
J Neurosci; 2011 Sep; 31(39):13890-6. PubMed ID: 21957251
[TBL] [Abstract][Full Text] [Related]
38. Enhancement of morphine analgesic effect with induction of mu-opioid receptor endocytosis in rats.
Hashimoto T; Saito Y; Yamada K; Hara N; Kirihara Y; Tsuchiya M
Anesthesiology; 2006 Sep; 105(3):574-80. PubMed ID: 16931992
[TBL] [Abstract][Full Text] [Related]
39. Tolerance to repeated microinjection of morphine into the periaqueductal gray is associated with changes in the behavior of off- and on-cells in the rostral ventromedial medulla of rats.
Tortorici V; Morgan MM; Vanegas H
Pain; 2001 Jan; 89(2-3):237-44. PubMed ID: 11166480
[TBL] [Abstract][Full Text] [Related]
40. Extracellular signal-regulated kinase 1/2 activation counteracts morphine tolerance in the periaqueductal gray of the rat.
Macey TA; Bobeck EN; Hegarty DM; Aicher SA; Ingram SL; Morgan MM
J Pharmacol Exp Ther; 2009 Nov; 331(2):412-8. PubMed ID: 19684256
[TBL] [Abstract][Full Text] [Related]
[Previous] [Next] [New Search]
